Personalized breast cancer screening programs could help women better understand their personal cancer risks and guide providers in recommending mammographic assessments based on these risks. 

Connie Lehman, MD, PhD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at the Massachusetts General Hospital, explains why she thinks contrast-enhanced mammography will likely become the go-to supplemental imaging modality for women with dense breasts.

Radiomics methodologies could change how care plans are managed for patients with breast cancer by identifying those most likely to benefit from specific treatments.

Society of Breast Imaging President John Lewin, MD, explains some of the new initiatives and technology in mammography that are designed to increase early breast cancer detection.

Dense breast experts Wendie Berg, MD, and JoAnn Pushkin, executive director of DenseBreast-info Inc., explain the current status of breast density patient inform laws, reimbursement and new technologies to aid cancer detection. 

Authors of the new study stated that their findings are “reassuring” for both clinicians and patients.

This image gallery shows examples from various breast imaging modalities, including digital breast tomosynthesis, ultrasound and breast MRI, in addition to clinical presentations of breast cancer and other pathologies.

The new paper describes the imaging characteristics of metaplastic carcinoma of the breast and correlates the findings with clinical and histopathological characteristics/diagnoses.